Skip to main navigation
Skip to search
Skip to main content
The Capital Region of Denmark's Research Portal Home
Help & FAQ
Dansk
English
Home
Hospitals/departments
Researchers
Research output
Activities
Prizes
Search by expertise, name or affiliation
Blood-retina barrier permeability in diabetes during acute ACE-inhibition
C B Engler, H H Parving,
E R Mathiesen
, M Larsen, H Lund-Andersen
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Blood-retina barrier permeability in diabetes during acute ACE-inhibition'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Diabetes
100%
Blood-retinal Barrier
100%
ACE Inhibition
100%
Barrier Permeability
100%
Captopril
75%
Placebo
50%
Diabetic Patients
50%
Retinopathy
50%
Hypertensive
50%
Insulin Independence
50%
Mean Arterial Pressure
25%
Placebo-controlled
25%
Controlled Crosses
25%
Acute Effects
25%
Placebo Treatment
25%
Geometric Mean
25%
Ophthalmic Examination
25%
Fundus Photography
25%
Fluorescein Angiography
25%
Structural Change
25%
Retinal Vessels
25%
Hydrostatic Force
25%
Continuous Blood Pressure
25%
Abnormal Leakage
25%
Vitreous Fluorometry
25%
Medicine and Dentistry
Placebo
100%
Diabetes
100%
Blood-Retinal Barrier
100%
Captopril
75%
Diabetes Mellitus
50%
Retinopathy
50%
Mean Arterial Pressure
25%
Fundus Photography
25%
Fluorometry
25%
Fluorescein Angiography
25%
Retinal Blood Vessel
25%
Vitreous
25%
Blood Pressure Measurement
25%
Neuroscience
Placebo
100%
Blood Retina Barrier
100%
Captopril
75%
Diabetes Mellitus
50%
Retinal Disease
50%
Crossover Study
25%
Retinal Blood Vessel
25%
Vitreous
25%
Angiography
25%
Fluorescein
25%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
100%
Captopril
75%
Diabetes Mellitus
50%
Retinopathy
50%
Fluorescein
25%
Immunology and Microbiology
Blood Retina Barrier
100%
Blood Pressure
25%
Mean Arterial Pressure
25%